Profil
Kristen Harrington-Smith currently works at ADC Therapeutics SA, as Chief Commercial Officer & Senior Vice President from 2022.
Ms. Harrington-Smith also formerly worked at eFFECTOR Therapeutics, Inc., as Independent Director from 2022 to 2024, ImmunoGen, Inc., as Chief Commercial Officer from 2021 to 2022, and Novartis Pharmaceuticals, as US Commercial Head-Hematology from 2020 to 2021.
Ms. Harrington-Smith received her undergraduate degree from Williams College and Masters Business Admin degree from Kenan-Flagler Business School.
Postes actifs de Kristen Harrington-Smith
| Sociétés | Poste | Début |
|---|---|---|
| ADC THERAPEUTICS SA | Corporate Officer/Principal | 17/11/2022 |
Anciens postes connus de Kristen Harrington-Smith
| Sociétés | Poste | Fin |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 21/06/2024 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 16/11/2022 |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/11/2021 |
Formation de Kristen Harrington-Smith
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ImmunoGen, Inc.
ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Williams College
Williams College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals
Novartis Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kenan-Flagler Business School
Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
















